280 related articles for article (PubMed ID: 25083344)
21. The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis.
Bampton A; Gittings LM; Fratta P; Lashley T; Gatt A
Acta Neuropathol; 2020 Nov; 140(5):599-623. PubMed ID: 32748079
[TBL] [Abstract][Full Text] [Related]
22. FUS/TLS-immunoreactive neuronal and glial cell inclusions increase with disease duration in familial amyotrophic lateral sclerosis with an R521C FUS/TLS mutation.
Suzuki N; Kato S; Kato M; Warita H; Mizuno H; Kato M; Shimakura N; Akiyama H; Kobayashi Z; Konno H; Aoki M
J Neuropathol Exp Neurol; 2012 Sep; 71(9):779-88. PubMed ID: 22878663
[TBL] [Abstract][Full Text] [Related]
23. The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons.
Honda D; Ishigaki S; Iguchi Y; Fujioka Y; Udagawa T; Masuda A; Ohno K; Katsuno M; Sobue G
FEBS Open Bio; 2013; 4():1-10. PubMed ID: 24319651
[TBL] [Abstract][Full Text] [Related]
24. FUS is phosphorylated by DNA-PK and accumulates in the cytoplasm after DNA damage.
Deng Q; Holler CJ; Taylor G; Hudson KF; Watkins W; Gearing M; Ito D; Murray ME; Dickson DW; Seyfried NT; Kukar T
J Neurosci; 2014 Jun; 34(23):7802-13. PubMed ID: 24899704
[TBL] [Abstract][Full Text] [Related]
25. The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span.
Wang JW; Brent JR; Tomlinson A; Shneider NA; McCabe BD
J Clin Invest; 2011 Oct; 121(10):4118-26. PubMed ID: 21881207
[TBL] [Abstract][Full Text] [Related]
26. ALS mutations in TLS/FUS disrupt target gene expression.
Coady TH; Manley JL
Genes Dev; 2015 Aug; 29(16):1696-706. PubMed ID: 26251528
[TBL] [Abstract][Full Text] [Related]
27. Making connections: pathology and genetics link amyotrophic lateral sclerosis with frontotemporal lobe dementia.
Fecto F; Siddique T
J Mol Neurosci; 2011 Nov; 45(3):663-75. PubMed ID: 21901496
[TBL] [Abstract][Full Text] [Related]
28. TDP-43 and FUS en route from the nucleus to the cytoplasm.
Ederle H; Dormann D
FEBS Lett; 2017 Jun; 591(11):1489-1507. PubMed ID: 28380257
[TBL] [Abstract][Full Text] [Related]
29. RNA Is a Double-Edged Sword in ALS Pathogenesis.
Zaepfel BL; Rothstein JD
Front Cell Neurosci; 2021; 15():708181. PubMed ID: 34349625
[TBL] [Abstract][Full Text] [Related]
30. Alterations in stress granule dynamics driven by TDP-43 and FUS: a link to pathological inclusions in ALS?
Aulas A; Vande Velde C
Front Cell Neurosci; 2015; 9():423. PubMed ID: 26557057
[TBL] [Abstract][Full Text] [Related]
31. [The FUS protein: Physiological functions and a role in amyotrophic lateral sclerosis].
Efimova AD; Ovchinnikov RK; Roman AY; Maltsev AV; Grigoriev VV; Kovrazhkina EA; Skvortsova VI
Mol Biol (Mosk); 2017; 51(3):387-399. PubMed ID: 28707655
[TBL] [Abstract][Full Text] [Related]
32. Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration-associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathways.
Wang T; Jiang X; Chen G; Xu J
Neurobiol Aging; 2015 Jan; 36(1):527-35. PubMed ID: 25192599
[TBL] [Abstract][Full Text] [Related]
33. Minor intron splicing is regulated by FUS and affected by ALS-associated FUS mutants.
Reber S; Stettler J; Filosa G; Colombo M; Jutzi D; Lenzken SC; Schweingruber C; Bruggmann R; Bachi A; Barabino SM; Mühlemann O; Ruepp MD
EMBO J; 2016 Jul; 35(14):1504-21. PubMed ID: 27252488
[TBL] [Abstract][Full Text] [Related]
34. A new subtype of frontotemporal lobar degeneration with FUS pathology.
Neumann M; Rademakers R; Roeber S; Baker M; Kretzschmar HA; Mackenzie IR
Brain; 2009 Nov; 132(Pt 11):2922-31. PubMed ID: 19674978
[TBL] [Abstract][Full Text] [Related]
35. Intracellular localization and splicing regulation of FUS/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations.
Kino Y; Washizu C; Aquilanti E; Okuno M; Kurosawa M; Yamada M; Doi H; Nukina N
Nucleic Acids Res; 2011 Apr; 39(7):2781-98. PubMed ID: 21109527
[TBL] [Abstract][Full Text] [Related]
36. DDX17 is involved in DNA damage repair and modifies FUS toxicity in an RGG-domain dependent manner.
Fortuna TR; Kour S; Anderson EN; Ward C; Rajasundaram D; Donnelly CJ; Hermann A; Wyne H; Shewmaker F; Pandey UB
Acta Neuropathol; 2021 Sep; 142(3):515-536. PubMed ID: 34061233
[TBL] [Abstract][Full Text] [Related]
37. Synaptic Paths to Neurodegeneration: The Emerging Role of TDP-43 and FUS in Synaptic Functions.
Ling SC
Neural Plast; 2018; 2018():8413496. PubMed ID: 29755516
[TBL] [Abstract][Full Text] [Related]
38. Molecular basis of ALS and FTD: implications for translational studies.
Liščić RM
Arh Hig Rada Toksikol; 2015 Dec; 66(4):285-90. PubMed ID: 26751860
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanisms linking loss of TDP-43 function to amyotrophic lateral sclerosis/frontotemporal dementia-related genes.
Koike Y
Neurosci Res; 2024 May; ():. PubMed ID: 38723906
[TBL] [Abstract][Full Text] [Related]
40. FUS-regulated region- and cell-type-specific transcriptome is associated with cell selectivity in ALS/FTLD.
Fujioka Y; Ishigaki S; Masuda A; Iguchi Y; Udagawa T; Watanabe H; Katsuno M; Ohno K; Sobue G
Sci Rep; 2013; 3():2388. PubMed ID: 23925123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
